HealthTree Logo
search more_vert
App Logo
person Sign In / Create Account
HealthTree University: Multiple Myeloma Basics Part 2 (2 of 2)
Posted: Jul 15, 2020
HealthTree University: Multiple Myeloma Basics Part 2 (2 of 2) image

Myeloma does some things to your body that you should be aware of. Bone lesions, thickening of your blood, and damage to your kidneys are all things to watch out for. It’s also important to know how high-risk or low-risk your disease is, as this is playing an increasingly important part in myeloma treatment. Below are some video excerpts from our HealthTree University curriculum to help you learn more about these important areas of your disease.

If you register in HealthTree to use HealthTree University (where you can watch these same videos), you can save and keep track of your progress, get points for answering quiz questions, bookmark videos, take notes, earn prizes [COMING SOON], and get access to all the other features of HealthTree.




2.06 — What are lytic and focal bone lesions and how common are they?

The difference between a lytic and focal bone lesion is useful to know, especially if you have bone lesions at diagnosis.


  • Dan Vogl, MD, MSCE of Penn Medicine - Abramson Cancer Center
  • Jens Hillengass, MD of Roswell Park Comprehensive Cancer Center

2.07 — What is hyperviscosity? How is it treated?

Hyperviscosity is a symptom of high protein in your blood, and it is good to know the symptoms so you know what to look out for.


  • Muzaffar Qazilbash, MD of MD Anderson Cancer Center

2.08 — What kidney dysfunction is associated with myeloma and why?

Kidney disease is one of the more common sites of organ damage due to myeloma, and it’s good to understand why this happens.


  • Dan Vogl, MD, MSCE of Penn Medicine - Abramson Cancer Center

2.09 — What is mSMART? What is risk stratification?

mSMART helps separate patients into risk groups, to help you know whether you’re at high risk or not.


  • Morie Gertz, MD, MACP of Mayo Clinic, Rochester

2.10 — What is Risk Stratification?

Knowing your level of risk can give you an important tool to understand your future treatment paths.


  • Adam Cohen, MD of Penn Medicine - Abramson Cancer Center
  • Omar Nadeem, MD of Dana-Farber Cancer Institute
  • Shaji Kumar, MD of Mayo Clinic, Rochester

Want more?

We have over 200 HealthTree University videos online at! Learn the basics (and the not-so-basics) of myeloma from some of the top myeloma doctors in the world!

Other HealthTree University Classes:

  1. Myeloma Basics Part 1
  2. Myeloma Basics Part 2
  3. Myeloma Basics Part 3
  4. Building Your HealthCare Team
  5. Becoming an Empowered Patient
  6. Starting Myeloma Treatment
  7. Autologous Stem Cell Transplant (ASCT)
  8. Precursor Conditions
  9. Relapsed and Refractory MM Treatment
  10. Myeloma Bone Disease
  11. Testing, Monitoring MM Markers
  12. [BETA] Multiple Myeloma Genetics and Precision Medicine
  13. Classes of Myeloma Drugs
  14. [BETA] COVID-19 and Multiple Myeloma
The author Cynthia Chmielewski

about the author
Cynthia Chmielewski

Cynthia (Cindy) Chmielewski is a professional educator and myeloma advocate. As a former teacher, she now teaches myeloma patients how to advocate for themselves as the Director of HealthTree University. You can follow her on Twitter @myelomateacher

Get the latest thought leadership on Multiple Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Multiple Myeloma Newsletter" for Multiple Myeloma news, life with Multiple Myeloma stories, Multiple Myeloma clinical trials, Multiple Myeloma 101 articles and events with Multiple Myeloma experts.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Janssen Oncology
Adaptive Biotechnologies
Amgen Oncology
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube